PDCD1 and pneumonitis: Grade 1 or 2 AEs associated with PD-1 inhibitor included the following: hypothyroidism (18.5%), fatigue (14.8%), increased transaminase increase level (11.1%), pneumonitis (11.1%), rash (11.1%), and diarrhea (7.4%).